Exercise medicine as adjunct therapy during RADIation for CAncer of the prostaTE to improve treatment efficacy – protocol for the ERADICATE study: a phase II randomised controlled trial
Abstract Background Tumour hypoxia resulting from inadequate perfusion is common in many solid tumours, including prostate cancer, and constitutes a major limiting factor in radiation therapy that contributes to treatment resistance. Emerging research in preclinical animal models indicates that exer...
Saved in:
Main Authors: | Oliver Schumacher, Robert U. Newton, Colin Tang, Raphael Chee, Sjoerd B. Vos, Ronny S. Low, David Joseph, Dennis R. Taaffe, Daniel A. Galvão |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-025-13555-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unusual Variant of Ameloblastoma with Calcifying Epithelial Odontogenic Tumor-like Areas in a Three-Year Old Child
by: Maryam Fatima, et al.
Published: (2024-01-01) -
Preparation, characterisation, and in vitro cancer‐suppression function of RNA nanoparticles carrying miR‐301b‐3p Inhibitor
by: Junjie Zhao, et al.
Published: (2023-05-01) -
Diagnostic challenge in chondromyxoid fibroma clinically mimicking neuroma
by: Aleksandra Izabela Masłowska, et al.
Published: (2024-10-01) -
Fibroblastic reticular cell tumor of eyelid: Rare case report and review of literature
by: Pragnya P. Mishra, et al.
Published: (2023-01-01) -
Focal therapy of prostate cancer: Use of artificial intelligence to define tumour volume and predict treatment outcomes
by: Wayne G. Brisbane, et al.
Published: (2025-01-01)